Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Analysts' Actions -- American Eagle, Mattel, Netflix, Tesaro and More
By TheStreet Staff
Oct 10, 2016 8:15 AM EDT
PRESS RELEASES
Titan Pharmaceuticals Announces Pricing Of $9.7 Million Registered Direct Offering
By PR Newswire
Jan 15, 2021 9:15 AM EST
PRESS RELEASES
Titan Pharmaceuticals Announces Reverse Stock Split
By PR Newswire
Nov 30, 2020 12:50 PM EST
PRESS RELEASES
Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT Pharma's Kappa Opioid Agonist Peptide, JT-09
By PR Newswire
Nov 2, 2020 8:00 AM EST
PRESS RELEASES
Titan Pharmaceuticals Announces Pricing Of $8.0 Million Underwritten Public Offering
By PR Newswire
Oct 28, 2020 3:00 PM EDT
PRESS RELEASES
Titan Pharmaceuticals Enters Into Definitive Agreement To Acquire JT Pharma's Kappa Opioid Agonist Peptide, JT-09
By PR Newswire
Oct 28, 2020 8:00 AM EDT
PRESS RELEASES
Titan Pharmaceuticals Announces Debt Settlement Agreement With Molteni And Horizon
By PR Newswire
Oct 26, 2020 6:30 AM EDT
PRESS RELEASES
Titan Pharmaceuticals Announces Pricing Of $2.7 Million Registered Direct Offering
By PR Newswire
Sep 24, 2020 9:00 AM EDT
PRESS RELEASES
Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation
By PR Newswire
Sep 18, 2020 4:45 PM EDT
PRESS RELEASES
Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare
By PR Newswire
Sep 15, 2020 8:30 AM EDT
PRESS RELEASES
Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation
By PR Newswire
Sep 14, 2020 8:30 AM EDT
PRESS RELEASES
Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020
By PR Newswire
Aug 10, 2020 4:30 PM EDT
PRESS RELEASES
Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020
By PR Newswire
May 11, 2020 4:03 PM EDT
PRESS RELEASES
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020
By PR Newswire
Mar 26, 2020 8:00 AM EDT
PRESS RELEASES
Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants
By PR Newswire
Mar 5, 2020 9:00 AM EST
PRESS RELEASES
Titan Pharmaceuticals Announces Pricing Of $2.2 Million Registered Direct Offering
By PR Newswire
Jan 7, 2020 9:15 AM EST
STOCKS
Analysts' Actions -- American Eagle, Mattel, Netflix, Tesaro and More
By TheStreet Staff
Oct 10, 2016 8:15 AM EDT
OPINION
5 stocks under $10 set to soar.
By Roberto Pedone
Jan 14, 2016 6:48 AM EST
MARKETS
Titan Pharmaceuticals (TTNP) Stock Soars on FDA Committee Treatment Approval
By Amanda Albright
Jan 13, 2016 10:15 AM EST
OPINION
4 Biotech Stocks Under $10 to Trade for Big Breakouts
By Roberto Pedone
Dec 13, 2015 12:45 PM EST
STOCKS
Titan Pharma Opioid Addiction Implant Passes Key Study Hurdle
By Adam Feuerstein
Jun 8, 2015 7:01 AM EDT
STOCKS
Leaders of <I>TheStreet's</I> Drug Approval Contest
By Adam Feuerstein
May 6, 2013 9:21 AM EDT
STOCKS
FDA Rejection of Titan's Probuphine Looks Like a Mugging
By Adam Feuerstein
May 1, 2013 10:19 AM EDT
STOCKS
Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy
By Adam Feuerstein
Apr 12, 2013 6:00 AM EDT
STOCKS
Most Profitable Second Quarter Biotech Stocks
By Adam Feuerstein
Apr 2, 2013 6:00 AM EDT
